BORIS KLEBANSKY
Pilots at Adele Ave, Demarest, NJ
License number
New Jersey A5068511
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
4 Adele Ave, Demarest, NJ 07627
Professional information
Modulation Of Chemosensory Receptors And Ligands Associated Therewith
US Patent:
8633186, Jan 21, 2014
Filed:
Jun 3, 2008
Appl. No.:
12/663634
Inventors:
Catherine Tachdjian - San Diego CA, US
Donald S. Karanewsky - Escondido CA, US
Xiao-Qing Tang - San Diego CA, US
Xiaodong Li - San Diego CA, US
Feng Zhang - San Diego CA, US
Guy Servant - San Diego CA, US
Qing Chen - San Diego CA, US
Vincent Darmohusodo - Encinitas CA, US
Richard Fine - Ridgewood NJ, US
Joseph R. Fotsing - San Diego CA, US
Jeffrey Robert Hammaker - San Diego CA, US
Xinshan Kang - Pine Brook NJ, US
Rachel D. A. Kimmich - San Diego CA, US
Boris Klebansky - Demarest NJ, US
Haitian Liu - San Diego CA, US
Goran Petrovic - San Diego CA, US
Jeffrey Yamamoto - San Diego CA, US
Hong Zhang - San Diego CA, US
Albert Zlotnik - San Diego CA, US
Karen Zoller - La Jolla CA, US
Donald S. Karanewsky - Escondido CA, US
Xiao-Qing Tang - San Diego CA, US
Xiaodong Li - San Diego CA, US
Feng Zhang - San Diego CA, US
Guy Servant - San Diego CA, US
Qing Chen - San Diego CA, US
Vincent Darmohusodo - Encinitas CA, US
Richard Fine - Ridgewood NJ, US
Joseph R. Fotsing - San Diego CA, US
Jeffrey Robert Hammaker - San Diego CA, US
Xinshan Kang - Pine Brook NJ, US
Rachel D. A. Kimmich - San Diego CA, US
Boris Klebansky - Demarest NJ, US
Haitian Liu - San Diego CA, US
Goran Petrovic - San Diego CA, US
Jeffrey Yamamoto - San Diego CA, US
Hong Zhang - San Diego CA, US
Albert Zlotnik - San Diego CA, US
Karen Zoller - La Jolla CA, US
Assignee:
Senomyx Inc. - San Diego CA
International Classification:
C07D 239/95, C07D 285/16, A61K 31/517, A61K 31/54
US Classification:
5142228, 544 11
Abstract:
The present invention includes methods for identifying modifiers of chemosensory receptors and their ligands, e. g. , by determining whether a test entity is suitable to interact with one or more interacting sites within the Venus flytrap domains of the chemosensory receptors, and modifiers capable of modulating chemosensory receptors and their ligands. The present invention also includes modifiers of chemosensory receptors and their ligands having Formula (I), its subgenus, and specific compounds. Furthermore, the present invention includes ingestible compositions comprising the modifiers of chemosensory receptors and their ligands and methods of using the modifiers of chemosensory receptors and their ligands to enhance the sweet taste of an ingestible composition or treat a condition associated with a chemosensory receptor. In addition, the present invention include processes for preparing the modifiers of chemosensory receptors and their ligands.
Pyridylpiperazines And Aminonicotinamides And Their Use As Therapeutic Agents
US Patent:
7390813, Jun 24, 2008
Filed:
Dec 20, 2002
Appl. No.:
10/326210
Inventors:
Michael D. Winther - Vancouver, CA
Richard M. Fine - Ridgewood NJ, US
Boris Klebansky - Demarest NJ, US
Heinz Gschwend - Santa Rosa CA, US
Daniel F. Harvey - San Diego CA, US
Richard M. Fine - Ridgewood NJ, US
Boris Klebansky - Demarest NJ, US
Heinz Gschwend - Santa Rosa CA, US
Daniel F. Harvey - San Diego CA, US
Assignee:
Xenon Pharmaceuticals Inc. - Burnaby, BC
International Classification:
A61K 31/495, C07D 401/04
US Classification:
514255, 544360
Abstract:
Novel compounds useful in the treatment of, prevention of or protection against diseases and/or conditions related to metabolic syndrome and lipid metabolism, especially diseases of fatty acid and cholesterol metabolism, such as those mediated by stearoyl-CoA desaturase, are disclosed along with methods of employing said compounds for such uses.
Compounds Including Substituted Thienopyrimidinone Derivatives As Ligands For Modulating Chemosensory Receptors
US Patent:
7928111, Apr 19, 2011
Filed:
Aug 8, 2007
Appl. No.:
11/836074
Inventors:
Catherine Tachdjian - San Diego CA, US
Xiao-Qing Tang - San Diego CA, US
Sara Werner - San Diego CA, US
Qing Chen - San Diego CA, US
Guy Servant - San Diego CA, US
Xiaodong Li - San Diego CA, US
Feng Zhang - San Diego CA, US
Haitian Liu - San Diego CA, US
Albert Zlotnik - San Diego CA, US
Mark Zoller - La Jolla CA, US
Boris Klebansky - Demarest NJ, US
Richard Fine - Ridgewood NJ, US
Xinshan Kang - Pine Brook NJ, US
Xiao-Qing Tang - San Diego CA, US
Sara Werner - San Diego CA, US
Qing Chen - San Diego CA, US
Guy Servant - San Diego CA, US
Xiaodong Li - San Diego CA, US
Feng Zhang - San Diego CA, US
Haitian Liu - San Diego CA, US
Albert Zlotnik - San Diego CA, US
Mark Zoller - La Jolla CA, US
Boris Klebansky - Demarest NJ, US
Richard Fine - Ridgewood NJ, US
Xinshan Kang - Pine Brook NJ, US
Assignee:
Senomyx, Inc. - San Diego CA
International Classification:
A61K 31/519
US Classification:
5142601, 424452, 424461, 424479, 424493, 544278
Abstract:
The present invention provides compounds including substituted thienopyrimidinone derivatives of Formula (IIc) as ligands for modulating chemosensory receptors:.
Nicotinamide Derivatives And Their Use As Therapeutic Agents
US Patent:
2005011, Jun 2, 2005
Filed:
Jul 6, 2004
Appl. No.:
10/885901
Inventors:
Jian-Min Fu - Burnaby, CA
Vishnumurthy Kodumuru - Burnaby, CA
Shaoyi Sun - Vancouver, CA
Michael Winther - Vancouver, CA
Richard Fine - Ridgewood NJ, US
Daniel Harvey - San Diego CA, US
Boris Klebansky - Demarest NJ, US
Heinz Gschwend - Santa Rosa CA, US
Wenbao Li - San Diego CA, US
Vishnumurthy Kodumuru - Burnaby, CA
Shaoyi Sun - Vancouver, CA
Michael Winther - Vancouver, CA
Richard Fine - Ridgewood NJ, US
Daniel Harvey - San Diego CA, US
Boris Klebansky - Demarest NJ, US
Heinz Gschwend - Santa Rosa CA, US
Wenbao Li - San Diego CA, US
International Classification:
A61K031/551, A61K031/496
US Classification:
514218000, 514253090, 514253110
Abstract:
Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I):
where m, n, p, V, R1, R2, R3, R4, R5 and R6 are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
Modulation Of Chemosensory Receptors And Ligands Associated Therewith
US Patent:
2008030, Dec 11, 2008
Filed:
Jun 8, 2007
Appl. No.:
11/760666
Inventors:
Xiaodong Li - San Diego CA, US
Feng Zhang - San Diego CA, US
Hong Xu - San Diego CA, US
Catherine Tachdjian - San Diego CA, US
Sara Werner - San Diego CA, US
Andrew Patron - San Marcos CA, US
Albert Zlotnik - San Diego CA, US
Mark Zoller - La Jolla CA, US
Boris Klebansky - Demarest NJ, US
Richard Fine - Ridgewood NJ, US
Xinshan Kang - Pine Brook NJ, US
Feng Zhang - San Diego CA, US
Hong Xu - San Diego CA, US
Catherine Tachdjian - San Diego CA, US
Sara Werner - San Diego CA, US
Andrew Patron - San Marcos CA, US
Albert Zlotnik - San Diego CA, US
Mark Zoller - La Jolla CA, US
Boris Klebansky - Demarest NJ, US
Richard Fine - Ridgewood NJ, US
Xinshan Kang - Pine Brook NJ, US
Assignee:
SENOMYX, INC. - San Diego CA
International Classification:
A61K 31/495, A61P 27/00, C07D 487/00, C12N 5/06, G01N 33/53, G06G 7/48
US Classification:
514249, 435375, 435 71, 544236, 703 11
Abstract:
The present invention provides screening methods for identifying modifiers of chemosensory receptors and their ligands, e.g., by determining whether a test entity is suitable to interact with one or more interacting sites within the Venus flytrap domains of the chemosensory receptors as well as modifiers capable of modulating chemosensory receptors and their ligands.
Modulation Of Chemosensory Receptors And Ligands Associated Therewith
US Patent:
2008030, Dec 11, 2008
Filed:
Jun 8, 2007
Appl. No.:
11/760592
Inventors:
Guy Servant - San Diego CA, US
Xiaodong Li - San Diego CA, US
Feng Zhang - San Diego CA, US
Haitian Liu - San Diego CA, US
Catherine Tachdjian - San Diego CA, US
Xiao-Qing Tang - San Diego CA, US
Sara Werner - San Diego CA, US
Qing Chen - San Diego CA, US
Albert Zlotnik - San Diego CA, US
Mark Zoller - La Jolla CA, US
Boris Klebansky - Demarest NJ, US
Richard Fine - Ridgewood NJ, US
Xinshan Kang - Pine Brook NJ, US
Xiaodong Li - San Diego CA, US
Feng Zhang - San Diego CA, US
Haitian Liu - San Diego CA, US
Catherine Tachdjian - San Diego CA, US
Xiao-Qing Tang - San Diego CA, US
Sara Werner - San Diego CA, US
Qing Chen - San Diego CA, US
Albert Zlotnik - San Diego CA, US
Mark Zoller - La Jolla CA, US
Boris Klebansky - Demarest NJ, US
Richard Fine - Ridgewood NJ, US
Xinshan Kang - Pine Brook NJ, US
Assignee:
SENOMYX, INC. - San Diego CA
International Classification:
A61K 31/495, A61K 31/517, A61K 31/519, A61P 27/00, C07D 487/00, C12N 5/06, G01N 33/53, G06G 7/48
US Classification:
5142601, 435375, 435 71, 5142663, 5142664, 544236, 703 11
Abstract:
The present invention provides screening methods for identifying modifiers of chemosensory receptors and their ligands, e.g., by determining whether a test entity is suitable to interact with one or more interacting sites within the Venus flytrap domains of the chemosensory receptors as well as modifiers capable of modulating chemosensory receptors and their ligands.
Nicotinamide Derivatives And Their Use As Therapeutic Agents
US Patent:
2009019, Aug 6, 2009
Filed:
Apr 14, 2009
Appl. No.:
12/423432
Inventors:
Jian-Min Fu - Coquitlam, CA
Vishnumurthy Kodumuru - Burnaby, CA
Shaoyi Sun - Coquitlam, CA
Michael D. Winther - Vancouver, CA
Richard M. Fine - Ridgewood NJ, US
Daniel F. Harvey - San Diego CA, US
Boris Klebansky - Demarest NJ, US
Heinz W. Gschwend - Santa Rosa CA, US
Wenbao Li - San Diego CA, US
Vishnumurthy Kodumuru - Burnaby, CA
Shaoyi Sun - Coquitlam, CA
Michael D. Winther - Vancouver, CA
Richard M. Fine - Ridgewood NJ, US
Daniel F. Harvey - San Diego CA, US
Boris Klebansky - Demarest NJ, US
Heinz W. Gschwend - Santa Rosa CA, US
Wenbao Li - San Diego CA, US
Assignee:
XENON PHARMACEUTICALS INC. - Burnaby
International Classification:
A61K 31/496, C07D 401/04, A61P 3/10
US Classification:
51425313, 544365
Abstract:
Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I):where m, n, p, V, R, R, R, R, Rand Rare defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
Multistream Encryption System For Secure Communication
US Patent:
5440640, Aug 8, 1995
Filed:
Oct 5, 1993
Appl. No.:
8/131542
Inventors:
Michael M. Anshel - New York NY
Izidor C. Gertner - New York NY
Dorian Goldfeld - Tenafly NJ
Boris A. Klebansky - Demarest NJ
Izidor C. Gertner - New York NY
Dorian Goldfeld - Tenafly NJ
Boris A. Klebansky - Demarest NJ
Assignee:
Arithmetica, Inc. - Wilmington DE
International Classification:
H04L 922
US Classification:
380 46
Abstract:
MUSE, a programmable multistream encryption system for secure communication provides dynamic cryptographic security and a highly efficient surveillance mechanism for transferring very large blocks of data (VLBD) subject to real-time constraints. Encryption varies pseudorandomly in both space and time. MUSE allows the user to specify a finite state machine which sequentially accepts parallel streams of data (VLBD) and encrypts this data in real time employing an arithmetic-algebraic pseudorandom array generator (PRAG). The method of enciphering is a one-time algebraic pad system which views the incoming data streams as elements from an algebraic alphabet (finite ring) and encrypts by adding to this a pseudorandom vector sequence iteratively generated from a single seed key. Decipherment is obtained by reversing this process.